Crossmark

Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda

Crossref DOI link: https://doi.org/10.1186/s12981-021-00331-5

Published Online: 2021-03-20

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nuwagira, Edwin

Lumori, Boniface A. E.

Muhindo, Rose

Kanyesigye, Michael

Amir, Abdallah

Muyindike, Winnie

Muzoora, Conrad
License Information

Text and Data Mining valid from 2021-03-20

Version of Record valid from 2021-03-20
More Information

Article History

Received: 25 September 2020

Accepted: 12 March 2021

First Online: 20 March 2021

Declarations

:

: The study protocol and tool were approved by the Mbarara University of Science and technology Ethics and Research Committee, Mbarara Regional Referral Hospital administration and the Uganda National Council of Science and Technology (UNCST) (Study number: HS193ES).

: Not applicable.

: The authors have no conflict of interest to declare.

Document is current

Any future updates will be listed below